BTIG Maintains Buy on Verastem, Lowers Price Target to $18
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
BTIG analyst Jeet Mukherjee maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $19 to $18.
BTIG analyst Jeet Mukherjee maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $19 to $18.